These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4977810)

  • 1. [On the organization of a department for invalids--chronic carriers of the agent of typhoid and paratyphoid B].
    Tamm OM; Pikhl KhO
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Mar; 45(3):87-8. PubMed ID: 4977810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problem of chronic typhoid and paratyphoid carriers from the sociological and epidemiologic viewpoint].
    Fiedler K
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1230-4. PubMed ID: 4994103
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methodological and organizational aspects of detecting chronic carriers of typhoid and paratyphoid bacteria (review of the literature in 1960-1971)].
    Priamukhina NS; Kolobova LF
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):32-8. PubMed ID: 4206260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of antibiotics on the formation of typhoid-paratyphoid bacteria carrier states].
    Ukhov AIa
    Antibiotiki; 1969 Aug; 14(8):763-7. PubMed ID: 4985087
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ways of increasing the effectiveness of examinations of workers in food production and food handling for typhoid-paratyphoid bacteria carrier state].
    Litinskiĭ IuI; Smirnova-Mutusheva MA; Godovannyĭ BA; Danilova LA; Golysheva AG
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):84-7. PubMed ID: 4253548
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Typhoid and paratyphoid fever].
    Trawinski H; Wendt S; Lippmann N; Heinitz S; von Braun A; Lübbert C
    Z Gastroenterol; 2020 Feb; 58(2):160-170. PubMed ID: 32050286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fever monitoring program in areas with high incidence of typhoid and paratyphoid fever in Guizhou province].
    Yao GH; Tang GP; Tian KC; Zhang J; Sun JL; Wang ZJ; Jiang YQ; Zhao QL; Chen X; Chen SF; Liu MQ; Lu R; Li M; Wang DM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):254-8. PubMed ID: 23759232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

  • 11. [USE OF THE VI-HEMAGGLUTINATION REACTION IN THE DIAGNOSIS OF TYPHOID FEVER AND BACILLARY CARRIERS].
    RUBTSOV IV
    Lab Delo; 1963 Aug; 9():25-6. PubMed ID: 14083297
    [No Abstract]   [Full Text] [Related]  

  • 12. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic biliary typhoid and paratyphoid carriers--results on 78 treated cases obtained in 16 years (1963 to 1978) (author's transl)].
    Hiraishi K; Sagara H; Niwano K; Seo T; Matsubara Y; Aiso Y; Iimura T; Ukai S; Inoue I; Karaki K; Kawagoe T; Mori M; Toyoda T
    Kansenshogaku Zasshi; 1982 Mar; 56(3):207-17. PubMed ID: 6809859
    [No Abstract]   [Full Text] [Related]  

  • 14. [The consistency of S. typhi and S. paratyphi B lysotypes in permanent disease carriers].
    Tram NT; Nass W
    Z Gesamte Hyg; 1969 Oct; 15(10):769-71. PubMed ID: 4984446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Simultaneous elimination of several lysotypes or presentation forms in typhus and paratyphus-B chronic carriers].
    Schneider P
    Offentl Gesundheitswes; 1973 Apr; 35(4):235-9. PubMed ID: 4270078
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
    Kheĭfets LB; Stanislavskiĭ ES; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Functional status of the liver in typhoid-paratyphoid bacterial carriers].
    Golubchikova TN
    Sov Med; 1966 Oct; 29(10):99-102. PubMed ID: 4970468
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.